EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation

Boryana Nikolova-Mladenova iD, Rositsa Mihaylova iD, Mariyana Atanasova iD, Zvetanka Zhivkova, Irini Doytchinova iD

Molecules · 2025

DOI: 10.3390/molecules30051015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Boryana Nikolova-Mladenova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Hydrazones, Antineoplastic Agents, Aldehydes, Drug Design. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, project No. BG-RRP-2.004-0004-C01., European Union NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dimethoxy derivatives of salicylaldehyde benzoylhydrazone containing a methoxy group on both aromatic rings were designed and synthesized. The compounds were obtained in high yields, and their structures were confirmed by elemental analysis and various spectral techniques. In vitro evaluation of dimethoxy hydrazones demonstrated potent activity against the leukemic cell lines at low micro- and nanomolar concentrations. Remarkably, two dimethoxy analogs showed exceptional antileukemic selectivity, with no toxicity observed in normal human embryonic kidney HEK-293 cells. In silico modeling identified likely interactions with the target, human cAbl kinase, and suggested a possible mechanism for their antileukemic activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrazonesAntineoplastic AgentsAldehydesDrug DesignHumansHEK293 CellsCell Line, TumorStructure-Activity RelationshipDrug Screening Assays, AntitumorMolecular StructureMolecular Docking SimulationCell Proliferation

Stichwörter der Autor:innen

antileukemic activityhydrazonesmethoxy groupsalicylaldehydeselectivity

Substanzen

HydrazonesAntineoplastic AgentsAldehydessalicylaldehyde

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
  • Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.

ORCID-Profile: Boryana Nikolova-Mladenova, Rositsa Mihaylova, Mariyana Atanasova, Irini Doytchinova

Förderung

  • European Union NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria, project No. BG-RRP-2.004-0004-C01.
  • European Union NextGenerationEU

Zitieren

APA

Nikolova-Mladenova, B., Mihaylova, R., Atanasova, M., Zhivkova, Z., & Doytchinova, I. (2025). Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation. Molecules. https://doi.org/10.3390/molecules30051015

Vancouver

Nikolova-Mladenova B, Mihaylova R, Atanasova M, Zhivkova Z, Doytchinova I. Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation. Molecules. 2025. doi:10.3390/molecules30051015

BibTeX
@article{NikolovaMladenova2025,
  author = {Nikolova-Mladenova, Boryana and Mihaylova, Rositsa and Atanasova, Mariyana and Zhivkova, Zvetanka and Doytchinova, Irini},
  title = {Salicylaldehyde Benzoylhydrazones with Anticancer Activity and Selectivity: Design, Synthesis, and In Vitro Evaluation},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30051015}
}
Kostenlos starten →